408 related articles for article (PubMed ID: 28100218)
1. Antiviral effect of compounds derived from the seeds of Mammea americana and Tabernaemontana cymosa on Dengue and Chikungunya virus infections.
Gómez-Calderón C; Mesa-Castro C; Robledo S; Gómez S; Bolivar-Avila S; Diaz-Castillo F; Martínez-Gutierrez M
BMC Complement Altern Med; 2017 Jan; 17(1):57. PubMed ID: 28100218
[TBL] [Abstract][Full Text] [Related]
2. The Antiviral and Virucidal Activities of Voacangine and Structural Analogs Extracted from
Monsalve-Escudero LM; Loaiza-Cano V; Zapata-Cardona MI; Quintero-Gil DC; Hernández-Mira E; Pájaro-González Y; Oliveros-Díaz AF; Diaz-Castillo F; Quiñones W; Robledo S; Martinez-Gutierrez M
Plants (Basel); 2021 Jun; 10(7):. PubMed ID: 34201900
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in silico anti-dengue activity of compounds obtained from Psidium guajava through bioprospecting.
Trujillo-Correa AI; Quintero-Gil DC; Diaz-Castillo F; Quiñones W; Robledo SM; Martinez-Gutierrez M
BMC Complement Altern Med; 2019 Nov; 19(1):298. PubMed ID: 31694638
[TBL] [Abstract][Full Text] [Related]
4.
Alagarasu K; Patil P; Kaushik M; Chowdhury D; Joshi RK; Hegde HV; Kakade MB; Hoti SL; Cherian S; Parashar D
Front Cell Infect Microbiol; 2022; 12():866452. PubMed ID: 35463636
[TBL] [Abstract][Full Text] [Related]
5. Indole alkaloids inhibit zika and chikungunya virus infection in different cell lines.
Monsalve-Escudero LM; Loaiza-Cano V; Pájaro-González Y; Oliveros-Díaz AF; Diaz-Castillo F; Quiñones W; Robledo S; Martinez-Gutierrez M
BMC Complement Med Ther; 2021 Aug; 21(1):216. PubMed ID: 34454481
[TBL] [Abstract][Full Text] [Related]
6. A perspective on targeting non-structural proteins to combat neglected tropical diseases: Dengue, West Nile and Chikungunya viruses.
Bhakat S; Karubiu W; Jayaprakash V; Soliman ME
Eur J Med Chem; 2014 Nov; 87():677-702. PubMed ID: 25305334
[TBL] [Abstract][Full Text] [Related]
7. Novel antiviral activity of baicalein against dengue virus.
Zandi K; Teoh BT; Sam SS; Wong PF; Mustafa MR; Abubakar S
BMC Complement Altern Med; 2012 Nov; 12():214. PubMed ID: 23140177
[TBL] [Abstract][Full Text] [Related]
8. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
[TBL] [Abstract][Full Text] [Related]
9. Effect of Sauropus androgynus L. Merr. on dengue virus-2: An in vitro and in silico study.
Joshi RK; Agarwal S; Patil P; Alagarasu K; Panda K; Prashar C; Kakade M; Davuluri KS; Cherian S; Parashar D; Pandey KC; Roy S
J Ethnopharmacol; 2023 Mar; 304():116044. PubMed ID: 36528212
[TBL] [Abstract][Full Text] [Related]
10. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S
Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124
[TBL] [Abstract][Full Text] [Related]
11. Arctigenin from Arctium lappa L. inhibits chikungunya virus by affecting its entry and replication.
Shukla S; Kakade M; Cherian S; Alagarasu K; Parashar D
Phytomedicine; 2024 Jun; 128():155491. PubMed ID: 38489894
[TBL] [Abstract][Full Text] [Related]
12. Searching for plant-derived antivirals against dengue virus and Zika virus.
de Castro Barbosa E; Alves TMA; Kohlhoff M; Jangola STG; Pires DEV; Figueiredo ACC; Alves ÉAR; Calzavara-Silva CE; Sobral M; Kroon EG; Rosa LH; Zani CL; de Oliveira JG
Virol J; 2022 Feb; 19(1):31. PubMed ID: 35193667
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of four types of bioflavonoid against dengue virus type-2.
Zandi K; Teoh BT; Sam SS; Wong PF; Mustafa MR; Abubakar S
Virol J; 2011 Dec; 8():560. PubMed ID: 22201648
[TBL] [Abstract][Full Text] [Related]
14. Vathasura Kudineer, an Andrographis based polyherbal formulation exhibits immunomodulation and inhibits chikungunya virus (CHIKV) under invitro conditions.
Hasan A; Devi Ms S; Sharma G; Narayanan V; Sathiyarajeswaran P; Vinayak S; Sunil S
J Ethnopharmacol; 2023 Feb; 302(Pt A):115762. PubMed ID: 36181982
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of nobiletin against chikungunya virus in vitro.
Lin SC; Chen MC; Li S; Lin CC; Wang TT
Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093
[TBL] [Abstract][Full Text] [Related]
16. Development of a Real-Time Cell Analysing (RTCA) method as a fast and accurate screen for the selection of chikungunya virus replication inhibitors.
Marlina S; Shu MH; AbuBakar S; Zandi K
Parasit Vectors; 2015 Nov; 8():579. PubMed ID: 26553263
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
[TBL] [Abstract][Full Text] [Related]
18. Plants extracts from Cameroon pharmacopeia strongly inhibit the Chikungunya virus infection by targeting entry and replication steps.
Simo Nemg FB; De S; Keshry SS; Mamidi P; Njayou FN; Demanou M; Moundipa Fewou P; Chattopadhyay S
J Ethnopharmacol; 2022 Oct; 296():115458. PubMed ID: 35728708
[TBL] [Abstract][Full Text] [Related]
19. Explorations on the antiviral potential of zinc and magnesium salts against chikungunya virus: implications for therapeutics.
Davuluri KS; Shukla S; Kakade M; Cherian S; Alagarasu K; Parashar D
Front Cell Infect Microbiol; 2024; 14():1335189. PubMed ID: 38895735
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of dengue and chikungunya virus strains circulating in New Delhi, India.
Afreen N; Deeba F; Khan WH; Haider SH; Kazim SN; Ishrat R; Naqvi IH; Shareef MY; Broor S; Ahmed A; Parveen S
Microbiol Immunol; 2014 Dec; 58(12):688-96. PubMed ID: 25346397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
